These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8824683)

  • 1. Assessing renal effects and renal protection.
    Rodicio JL; Ruilope LM
    J Hypertens Suppl; 1995 Dec; 13(4):S19-25. PubMed ID: 8824683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
    Rodicio JL
    Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are there differences in the renal effects of calcium antagonists?
    Leonetti G; Rappelli A
    J Hypertens Suppl; 1993 Mar; 11(1):S45-8. PubMed ID: 8483022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin reduces renal blood flow through vasoconstriction of arcuate arteries in the hydronephrotic rat model.
    Zimmerhackl LB; Fretschner M; Steinhausen M
    Klin Wochenschr; 1990 Feb; 68(3):166-74. PubMed ID: 2314004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipophilic dihydropyridines provide renal protection from cyclosporin toxicity.
    Rodicio JL; Morales JM; Ruilope LM
    J Hypertens Suppl; 1993 Dec; 11(6):S21-5. PubMed ID: 8169378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal hemodynamic effects of calcium antagonists.
    Loutzenhiser RD; Epstein M; Hayashi K
    Am J Cardiol; 1989 Sep; 64(11):41F-45F. PubMed ID: 2782270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of calcium channel blockade on adrenergically induced renal vasoconstriction in rat models of renal impairment.
    Khan AH; Sattar MA; Abdullah NA; Johns EJ
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):501-8. PubMed ID: 19673932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium antagonists and the kidney.
    Chellingsworth M; Kendall MJ
    J Hum Hypertens; 1987 Jun; 1(1):3-8. PubMed ID: 3334055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium antagonists and the kidney: implications for renal protection.
    Epstein M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 10():S64-70. PubMed ID: 1725007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diltiazem modulates cyclosporin A induced renal hemodynamic effects but not its effect on plasma endothelin-1.
    Asberg A; Christensen H; Hartmann A; Berg KJ
    Clin Transplant; 1998 Oct; 12(5):363-70. PubMed ID: 9787942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive therapy and renal function.
    Mimran A
    J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S19-25. PubMed ID: 8872296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium antagonists and the renal hemodynamic response to vasoconstrictors.
    Loutzenhiser R; Epstein M
    Ann N Y Acad Sci; 1988; 522():771-84. PubMed ID: 3377380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel blockade and renal function.
    Odar-Cederlöf I
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():81-9. PubMed ID: 3521200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effects of manidipine hydrochloride. A new calcium antagonist in hypertensive patients.
    Takabatake T; Ohta H; Sasaki T; Satoh S; Ohta K; Ise T; Kobayashi K
    Eur J Clin Pharmacol; 1993; 45(4):321-5. PubMed ID: 8299663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of calcium antagonists on the hypertensive kidney.
    Reams GP; Bauer JH
    Cardiovasc Drugs Ther; 1990 Oct; 4(5):1331-5. PubMed ID: 2278868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of NZ-105, a new calcium antagonist, on renal function in anesthetized spontaneously hypertensive rats.
    Yokoyama T; Masuda Y; Sakai T; Tanaka S; Tomita K
    J Cardiovasc Pharmacol; 1992 Jun; 19(6):851-6. PubMed ID: 1376803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of the renal hemodynamic response to vasoconstrictors by calcium antagonists.
    Loutzenhiser R; Epstein M
    Am J Nephrol; 1987; 7 Suppl 1():7-16. PubMed ID: 3442293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.